These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1565532)

  • 1. Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group.
    Hoppe JE
    Pediatr Infect Dis J; 1992 Mar; 11(3):189-93. PubMed ID: 1565532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
    Langley JM; Halperin SA; Boucher FD; Smith B;
    Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for whooping cough (pertussis).
    Altunaiji S; Kukuruzovic R; Curtis N; Massie J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004404. PubMed ID: 15674946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection.
    Halperin SA; Bortolussi R; Langley JM; Eastwood BJ; De Serres G
    Pediatrics; 1999 Oct; 104(4):e42. PubMed ID: 10506267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
    Ginsburg CM; McCracken GH; Crow SD; Dildy BR; Morchower G; Steinberg JB; Lancaster K
    Am J Dis Child; 1984 Jun; 138(6):536-9. PubMed ID: 6372437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pertussis treatment with erythromycin ethylsuccinate and stearate according to age.
    Kawai H; Aoyama T; Goto A; Iwai H; Murase Y
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1324-9. PubMed ID: 7829900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for whooping cough (pertussis).
    Altunaiji S; Kukuruzovic R; Curtis N; Massie J
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD004404. PubMed ID: 17636756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis.
    Hoppe JE; Halm U; Hagedorn HJ; Kraminer-Hagedorn A
    Infection; 1989; 17(4):227-31. PubMed ID: 2548964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.
    Bergquist SO; Bernander S; Dahnsjö H; Sundelöf B
    Pediatr Infect Dis J; 1987 May; 6(5):458-61. PubMed ID: 2885802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.
    Halperin SA; Bortolussi R; Langley JM; Miller B; Eastwood BJ
    Pediatrics; 1997 Jul; 100(1):65-71. PubMed ID: 9200361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin estolate for treatment of pertussis.
    Torre D; Maggiolo F; Quadrelli C; Sampietro C
    Pediatr Infect Dis; 1986; 5(6):719-20. PubMed ID: 3797311
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of an erythromycin for the treatment of pertussis.
    Nahata MC
    Drug Intell Clin Pharm; 1988 Nov; 22(11):895-8. PubMed ID: 3069427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group.
    Scholz H; Noack R
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):470-8. PubMed ID: 9764549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
    Bérubé D; Kirouac D; Croteau D; Bergeron MG; Lebel M
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1227-30. PubMed ID: 3142349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prevention of pertussis by antimicrobial agents (Part II).
    Hoppe JE; Haug A
    Infection; 1988; 16(3):148-52. PubMed ID: 3042626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.